New technologies emerging from the Human Genome Project and the rapidly expanding direct-to-consumer DNA testing have provided a challenging environment for the entry of pharmacogenomics into ...

The VA Medical Center in North Las Vegas says they are the first hospital in the region to offer a new kind of testing.

As a result, a major challenge for companies designing DNA-based tests is to develop dependable, economical, high-throughput genotyping platforms, and a major challenge for pharmacogenomic science ...

Pharmacogenomics today is a wide-ranging discipline that has identified many inherited DNA variants that make people ... cells to create relevant cells to test, in this case neurons and glia ...

If a pharmacogenomic test result can significantly impact on ... practices for prospective systematic collection and storage of DNA for genotyping of all study subjects enrolled in randomized ...

Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...

Emergen Research Logo The DNA Testing market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 81.82 billion in 2033, ...